Please text and tell us what you likeIs the AI market a ticking time bomb or a goldmine waiting to be tapped? Join us as Clem Miller helps dissect the current AI landscape, paralleled with the tech boom of 2000, and clarifies whether companies like Nvidia are the kings of the hill or just on a temporary pedestal. We’ll also explore the strategic pivot towards robust defensive stocks—think healthcare and consumer staples—as a buffer against market volatility. Plus, we're challenging the buzz around obesity drugs from giants like Lilly and Novartis, questioning if they're truly revolutionary or just another bubble.In this insightful episode, we delve into crucial financial metrics such as short interest ratios, beta, and PEG ratios to provide you with a comprehensive framework for evaluating stocks. Discover the red flags and green signals, especially for high PEG stocks like Costco. Additionally, dive deep into AI-related semiconductor stocks, with a keen focus on secondary opportunities in companies like Broadcom and ASML. We also touch on the profound impact of company culture on long-term growth, particularly at Nvidia and Elon Musk's ventures. Whether you're a market veteran or a novice investor, this episode promises actionable insights to navigate the unpredictable AI market. Straight Talk for All - Nonsense for NonePlease check out our other podcasts:https://skepticsguidetoinvesting.buzzsprout.com Disclaimer - These podcasts are not intended as investment advice. Individuals please consult your own investment, tax and legal advisors. They provide these insights for educational purposes only.

Ver todos los episodios